Pramodini Medicare IPO Details
Pramodini Medicare IPO Summary
Pramodini Medicare IPO opens for subscription on 12 Aug 2026 and closes on 14 Aug 2026.The IPO will be listed on NSE with the tentative listing date set for 19 Aug 2026.
Pramodini Medicare IPO price band has been fixed at ₹110 – ₹118 per share. The face value is ₹10 per share with a lot size of 1200.
Pramodini Medicare IPO total issue size comprises 58,51,200 shares (aggregating up to ₹69.04 Cr). This includes a fresh issue of 53,50,800 shares (aggregating up to ₹63.14 Cr). Offer for Sale consists of 5,00,400 shares (aggregating up to ₹5.90 Cr). Pre-issue shareholding stands at 1,66,94,795, which will increase to 2,20,45,595 post-issue.
Pramodini Medicare IPO carries a ₹0 (0%) GMP, reflecting investor sentiment.
Pramodini Medicare IPO Lot Size :Individual Minimum is 2 lots (2,400 shares) amounting to ₹283,200. Individual Maximum is 2 lots (2,400 shares) amounting to ₹283,200. SHNI Minimum is 3 lots (3,600 shares) amounting to ₹424,800. SHNI Maximum is 7 lots (8,400 shares) amounting to ₹991,200. BHNI Minimum is 8 lots (9,600 shares) amounting to ₹1,132,800.
Pramodini Medicare IPO Details
Pramodini Medicare IPO Dates
- 12 Aug 2026Opening dateOpen
- 14 Aug 2026Closing dateClose
- 17 Aug 2026Allotment Date Allotment
- 18 Aug 2026Initiation of RefundsRefund
- 18 Aug 2026Credit of SharesCredit
- 19 Aug 2026Listing dateListing
Pramodini Medicare IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual Minimum | 2 | 2400 | ₹283,200 |
| Individual Maximum | 2 | 2400 | ₹283,200 |
| SHNI Minimum | 3 | 3600 | ₹424,800 |
| SHNI Maximum | 7 | 8400 | ₹991,200 |
| BHNI Minimum | 8 | 9600 | ₹1,132,800 |
Pramodini Medicare IPO Reservation
Promoter Holding
Documents
Pramodini Medicare IPO Valuations
Pramodini Medicare Financial Information
| Period Ended | 31 Mar 2026 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Assets | 93.62 | 56.45 | 48.78 |
| Total Income | 63.38 | 38.55 | 35.79 |
| Profit After Tax | 17.38 | 11.14 | 7.14 |
| EBITDA | 30.90 | 20.97 | 15.53 |
| NET Worth | 53.15 | 35.77 | 24.75 |
| Reserves and Surplus | 36.46 | 34.49 | 23.46 |
| Total Borrowing | 17.85 | 10.81 | 11.96 |
| Amount in ₹ Crore | |||
About Pramodini Medicare IPO
Incorporated in 2000, Pramodini Medicare Limited is a diagnostic service provider in India offering technology-enabled diagnostic services across radiology, clinical laboratory, and nuclear medicine segments. The company provides services to public hospitals, private hospitals, public sector undertakings (PSUs), medical colleges, and private diagnostic centres across tier I, II, and III cities.
Its service portfolio includes radiology services such as MRI, CT scans, X-ray, ultrasound with colour doppler, mammography, Dexa scan, and interventional radiology; clinical laboratory services including haematology, microbiology, immunology, pathology, and biochemistry; and nuclear medicine services such as PET-CT, SPECT, and nuclear therapy. The company also operates a 24×7 teleradiology unit from Vijayawada and a processing laboratory at the same location.
Service Model
- Public-Private Partnership (PPP): Operates diagnostic centres within government hospitals and medical colleges through long-term MOUs.
- Private-Private Partnership (Pvt-Pvt): Establishes and manages diagnostic centres inside private hospitals under partnership agreements.
- Strategic Partnerships with PSUs: Collaborates with Government of India PSUs to operate diagnostic and imaging centres across multiple states.
- Standalone Diagnostic Centres: Operates its own diagnostic centres and laboratories, serving both individual patients and hospitals.
- Location-Specific Agreements: Each diagnostic centre operates under separate MOUs or contracts with terms customized for the respective location.
The business operates through four models: public-private partnership (PPP) with government hospitals and teaching institutions, private-private partnerships with hospitals, strategic partnerships with PSUs, and standalone private diagnostic centres. As of August 04, 2026, the company operated 16 diagnostic centres across seven states.
As of March 31, 2026, the company had 161permanent employees.
Strength Of Pramodini Medicare IPO
- Establishing a Strategic presence across various states of India.
- Strengthening Our Network with Diversified Models.
- Technical Capability with robust IT Infrastructure.
- Dedicated Management Team with Significant Industry Experience.
- Track record of revenue and financial performance.
- Diverse Customer cum Patient Base.
Risk Of Pramodini Medicare IPO
- A significant portion of our revenue from operations is derived from MOUs with government authorities under Public Private Partnership (PPP) arrangements. Any non-renewal, modification, or termination of such MOUs, or delays or failures in realizing payments from government authorities, may materially and adversely affect our business, financial condition and results of operations.
- Concentrated emphasis on radiology services also exposes us to substantial risks that could adversely impact our operations, financial performance, and long-term growth prospects.
- We derive substantial portion of our revenue from the state of Andhra Pradesh and any loss of business in such regions could have an adverse effect on our business, results of operations and financial condition.
- We are majorly dependent on certain key customers cum patients for a substantial portion of our revenues. Loss of relationship with any of these customers cum patients may have a material adverse effect on our profitability and results of operations.
- We derive a significant portion of our revenue from government authorities (B2G). Any reduction in revenue from them or delays in payments by government authorities, may adversely affect our business, financial condition and results of operations.
- Failure to establish and comply with appropriate quality standards when performing diagnostics services could result in litigation and liability for us and could materially and adversely affect its reputation and results of operations.
- We rely on our information technology systems in providing our diagnostic services and managing our operations, and any disruption to such systems or networks could adversely affect our business operations, reputation and financial performance.
- Any inadequacy in packaging, collection of, or failure or delay in the delivery of, specimens to our diagnostic centres could compromise or destroy the integrity of such specimens, which could adversely affect our business, results of operations and financial condition.
- The prices that we can charge for our diagnostic services are dependent on recommended or mandatory fees fixed under the terms of the MOUs entered into with public sector enterprises, state governments and some of private medical establishments.
- We have not yet placed orders in relation to the capital expenditure requirements of the Company towards purchase of certain medical equipments for our existing and proposed diagnostic centres. In the event of any delay in placing the orders, or if the vendors are unable to provide the equipments in a timely manner, or at all, the same may result in time and cost overruns.
Objectives Pramodini Medicare IPO
1. Funding of capital expenditure for purchase of Medical Equipments towards Existing and Proposed Diagnostic Centres
2. General corporate purposes and unidentified inorganic acquisition
Company Contact Details
D. No: - 29-4-54K, CSI Complex, Prakasam Road, Suryaraopet
Vijayawada, Andhra Pradesh , 520002
Phone: +91 9985782727
Email: investors@pramodinidiagnostics.com
Website: https://www.pramodinidiagnostics.com/
Registrar Contact Details
Pramodini Medicare FAQs
The Pramodini Medicare IPO is a SME public issue comprising 5851200 equity shares with a face value of ₹10 each, aggregating to a total issue size of ₹69.04 Cr. The issue price has been fixed at ₹118 per equity share, and the minimum application size is 1200 shares.
The IPO opens for subscription on 12 Aug 2026, and closes on 14 Aug 2026.
Purva Sharegistry India Pvt Ltd has been appointed as the registrar to the issue. The equity shares are proposed to be listed on the NSE
As of now, the current GMP stands at ₹0 (0%).
Quick Links
Comments
